1
/
의
1
AntibodySystem
SKU(재고 관리 코드):KDD82501
Ifabotuzumab ELISA Kit
Ifabotuzumab ELISA Kit
Catalog No.: KDD82501
| Catalog No. | KDD82501 |
|---|---|
| Product name | Ifabotuzumab ELISA Kit |
| Size | 96 T |
| Description | PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human EPHA3 has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Ifabotuzumab in the sample competitively binds to the pre-coated protein with biotin-labeled Ifabotuzumab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Ifabotuzumab bound in the initial step. The color development is stopped and the intensity of the color is measured. |
| Applications | Used for the quantitative determination of Ifabotuzumab concentration in serum and plasma. |
| Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. |
| Detection method | Colorimetric |
| Precision | CV<20% |
| Sample type | Plasma, Serum |
| Assay type | Quantitative |
| Sensitivity | 18.17 ng/mL |
| Range | 12.5 - 800 ng/mL |
| Recovery | 80-120% |
| Background | Ifabotuzumab (formerly KB004) is a first-in-class therapeutic non-fucosylated IgG1 (human f-allotype) monoclonal antibody being developed by Humanigen (formerly KaloBios Pharmaceuticals) for the treatment of cancer. The drug was licensed from the Ludwig Institute for Cancer Research. The molecule contains a human antibody constant region with V-regions that are 92% identical to human germ-line sequences. Ifabotuzumab targets the ephrin type-A receptor 3 (EphA3) tyrosine kinase. In non-clinical studies, Ifabotuzumab demonstrated potent ex-vivo cell killing of EphA3+ tumor cells obtained from patients with hematologic malignancies. |
| Alternative Names | Fibatuzumab, KB-004, , CAS: 1234137-51-9 |
| Shipping | 2-8 ℃ |
| Note | For Research Use Only. |
Share
